Click here to narrow your options by answering a few questions.
   

Prostate Cancer Treatment Guide

Treatment
Description
Prostate Cancer
Patient Profile
Prostate Cancer
Treatments
Prostate Cancer
Survival Rates
Prostate Cancer
Side Effects
Therapy News View Procedures Share Your Experience

Watchful
Waiting

Watchful Waiting

Also called expectant therapy, patient undergoes careful monitoring instead of more aggressive therapy. Watchful Waiting

Also called expectant therapy, patient undergoes careful monitoring instead of more aggressive therapy.

click to learn more

Learn More

Expectant Therapy
Patients

Recommended to those with low Gleason and PSA levels, and nonpalpable tumors. Expectant Therapy
Patients

Recommended to those with low Gleason and PSA levels, and nonpalpable tumors.

click to learn more

Learn More

Monitoring and Care

Expectant therapy includes regular visits to a doctor for prostate specific antigen (PSA) tests and digital rectal exams. Monitoring and Care

Expectant therapy includes regular visits to a doctor for prostate specific antigen (PSA) tests and digital rectal exams.

click to learn more

Learn More

Watchful Waiting Outcomes

Because prostate cancer is usually slow-growing, many men opt for and benefit from watchful waiting. Watchful Waiting
Outcomes

Because prostate cancer is usually slow-growing, many men opt for and benefit from watchful waiting.

click to learn more

Learn More

Risks of
Watchful Waiting

Cancer may grow between monitoring visits and quickly spread to other parts of the body. Risks of
Watchful Waiting

Cancer may grow between monitoring visits and quickly spread to other parts of the body.

click to learn more

Learn More

Prostate News

Click here for the latest news on Watchful Waiting. Prostate News

Click here for the latest news on Watchful Waiting.

click to learn more

Learn More

Watchful Waiting
Videos

Click here to view Watchful Waiting procedures. Watchful Waiting
Videos

Click here to view Watchful Waiting procedures.

click to learn more

Learn More

Watchful Waiting
Experiences


Click here to share your Watchful Waiting experiences.Watchful Waiting
Experiencse

Click here to share your Watchful Waiting experiences.

click to learn more


Learn More

Brachytherapy

Chemotherapy

Cryotherapy & Cryosurgery

Hormone
Therapy

Radiation
Therapy

Prostatectomy

Robotic Prostatectomy

Complementary
and
Alternative Medicine

High Intensity
Focused
Ultrasound (HIFU)

Emerging Technologies

 

Results of Treating Prostate Cancer with Watchful Waiting

“Watchful Waiting and Factors Predictive of Secondary Treatment of Localized Prostate Cancer”
WU, HONGYAN; SUN, LEON; MOUL, JUDD W.; WU, HONGYU; McLEOD, DAVID G.; AMLING, CHRISTOPHER; LANCE, RAYMOND; KUSUDA, LEO; DONAHUE, TIMOTHY; FOLEY, JOHN; CHUNG, ANDREW; SEXTON, WADE; SODERDAHL, DOUGLAS Journal of Urology. 171(3):1111-1116, March 2004

For some patients with localized prostate cancer, watchful waiting remains a viable treatment option. Doctors in this study evaluated demographic, clinical, and outcome characteristics of patients choosing this treatment as an initial strategy. Throughout the study they were able to determine certain factors that may predict an eventual development to secondary treatment. From 1990 to 2001, 8,390 patients were diagnosed with prostate cancer, out of which 1,158 patients choose to begin with watchful waiting. Of the 1,158 patients, most were older, had a lower PSA level at diagnosis, and were more likely to have lower stage and lower grade cancers than patients who had chosen more aggressive treatment options. Doctors discovered that age, PSA, and clinical stage were all significant factors in the prediction of whether or not secondary treatment is needed.


“Time Trends and Characteristics of Men Choosing Watchful Waiting for Initial Treatment of Localized Prostate Cancer”
HARLAN, SUSAN R.; COOPERBERG, MATTHEW R.; ELKIN, ERIC P. +; LUBECK, DEBORAH P.; MENG, MAXWELL V.; MEHTA, SHILPA S.; CARROLL, PETER R. Journal of Urology. 170(5):1804-1807, November 2003.

In this study 402 patients from The Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) chose watchful waiting as their initial treatment between 1989 and 2000. Doctors examined patients at 3-year intervals. The use of watchful waiting increased from 7.5% in 1989 to 1991 to 9.5% in 1992 to 1994 and then decreased during the next 6 years to 5.5% in 1998 to 2000. As time progressed there was an increase in watchful waiting patients with T1 cancer and a PSA of 10 or less. Also they were generally around 75 years old at the time of treatment with Medicare insurance.


“Prostate Cancer Characteristics and Prostate Specific Antigen Changes in Screening Detected Patients Initially Treated with a Watchful Waiting Policy”
de VRIES, STIJN H.; RAAIJMAKERS, RENE; KRANSE, RIES; BLIJENBERG, BERT G.; SCHRODER, F H. Journal of Urology. 172(6, Part 1 of 2):2193-2196, December 2004.

Patients in this analysis were chosen from The European Randomized Study of Screening for Prostate Cancer and had proven prostate cancer and a PSA less than 10ng/mL. One hundred and ninety one patients chose watchful waiting based on their own personal desire or the advice from their physician. Patients were generally around 69 years old and 92.6% had a Gleason score of approximately 3 or lower. After 12 months 133 patients were included in the follow-up. Of 133, 35 patients (29.2%) had a negative PSA slope. There were 30 patients who decided to alter their treatment during the follow-up period. In order to validate these results further follow-up is needed.

 
 
 

 
Prostate Cancer Patient Discussion Group

 

 
 
 

Coping with Prostate Cancer      Are You at Risk for Prostate Cancer?      Prostate Cancer News     Glossary

 Home     Contact Us     Disclaimer    Privacy Policy     Resources     Add URL      Site Map